EP3651725A1

EP3651725A1 - Sunscreen with protection against textile spotting due to 2,4-bis-{[4-(2-ethyl-hexyl-oxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-1,3,5-triazine

Info

Publication number: EP3651725A1
Application number: EP18740127.8A
Authority: EP
Inventors: Kathrin Reske; Shimoda Toshihiko; Janina ZIPPEL; Andreas Bleckmann; Doreen Gutzke
Original assignee: Beiersdorf AG
Current assignee: Beiersdorf AG
Priority date: 2017-07-13
Filing date: 2018-06-29
Publication date: 2020-05-20
Also published as: DE102017212017A1; US20200163856A1; WO2019011670A1

Abstract

The invention relates to a cosmetic preparation containing 2,4-Bis-{[4-(2-ethyl- hexyloxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-1,3,5-triazine (Inc.: Bis-ethylhexyloxyphenol methoxyphenyl triazines), which is encapsulated with cellulose acetate, and to methods and to uses of 2,4-Bis-{[4-(2-ethyl-hexyloxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-,3,5-triazine (Inc.: Bis-ethylhexyloxyphenol methoxyphenyl triazines) which is encapsulated with cellulose acetate.

Description

description

Sunscreen agent with protection against textile staining by 2,4-bis - {[4- (2-ethyl-hexyl-oxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1, 3,5-triazine

The present invention relates to a cosmetic preparation containing 2,4-bis - {[4- (2-ethylhexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1, 3,5-triazine ( INCI: bis-ethylhexyloxyphenol methoxyphenyl triazine) encapsulated with cellulose acetate and methods and uses of 2,4-bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4 -methoxyphenyl) - 1, 3,5-triazine (INCI: bis-Ethylhexyloxyphenol methoxyphenyl triazines), which with

Cellulose acetate is encapsulated.

The trend away from the noble paleness to the "healthy, sporty brown skin" has been unbroken for years, to achieve this, people are putting their skin on the skin

Solar radiation, as this causes a pigmentation in the sense of melanin formation. However, the ultraviolet radiation of sunlight also has a damaging effect on the skin. In addition to the acute injury (sunburn), long-term damage such as an increased risk of developing skin cancer occurs due to excessive exposure to light from the UVB range (wavelength: 280-320 nm). The excessive action of UVB and UVA radiation (wavelength: 320-400 nm) also leads to a weakening of the elastic and collagen fibers of the connective tissue. This leads to numerous

phototoxic and photoallergic reactions and leads to premature aging of the skin. To protect the skin, therefore, a number of sunscreen filter substances has been developed which can be used in cosmetic preparations. These UVA and UVB filters are in the form of positive lists in most industrialized countries such as Appendix 7 of the

Cosmetics Regulation summarized. However, the large number of commercially available sunscreens must not disguise the fact that these prior art preparations contain a number of

Have disadvantages. Cosmetic preparations, such as sunscreen preparations applied to the skin, regularly (intentionally or unintentionally) come into contact with garments and items of laundry (eg towels) on which they are (eg, "attrition" or "sucked" by the fibers). to adhere in part. In this way, depending on the nature of the ingredients, especially on bright textiles stains and discoloration. These discolorations are particularly due to non-water soluble UVA and broadband filters such as 2,4-bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1,3 , 5-triazine (INCI: bis-ethylhexyloxyphenol methoxyphenyl triazines) caused. The stains are difficult to remove by washing with conventional detergents and even increase during the washing process by interactions with ions of the wash water.

It was therefore the object of the present invention to eliminate the disadvantages of the prior art and to provide a cosmetic preparation (in particular a sunscreen) containing non-water-soluble broadband filters such as 2,4-bis - {[4- (2-ethylhexyloxy) - 2-hydroxy] - phenyl} -6- (4-methoxyphenyl) -1, 3,5-triazine (INCI: bis-Ethylhexyloxyphenol methoxyphenyl triazines) to develop, which can be more easily washed out of the contaminated with the preparation textiles.

The object is surprisingly achieved by a cosmetic preparation containing 2,4-bis {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1,3,5- triazine (INCI: bis-ethylhexyloxyphenol methoxyphenyl triazine) which is encapsulated with cellulose acetate.

The object is further achieved by a process for facilitating the leachability of 2,4-bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1,3 , 5-triazine (INCI: bis-ethylhexyloxyphenol methoxyphenyl triazines) containing cosmetic preparations of textiles, characterized in that the cosmetic preparation, the 2,4-bis - {[4- (2-ethylhexyloxy) -2-hydroxy] - phenyl} -6- (4-methoxyphenyl) -1, 3,5-triazine (INCI: bis-ethylhexyloxyphenol methoxyphenyl triazines) in cellulose acetate-encapsulated form.

The object is not least solved by the use of 2,4-bis - {[4- (2-ethylhexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1,3,5- triazine (INCI: bis-ethylhexyloxyphenol methoxyphenyl triazine), which is encapsulated with cellulose acetate, in cosmetic preparations to facilitate the washability of this UV protection filter from textiles contaminated with the preparations.

Although the prior art is familiar with polymethyl methacrylate (PMMA) encapsulated UV filters (eg DE102014206147, DE102014206156, DE102014206152), these documents could not point the way to the present invention. In the context of the present disclosure, the formulations relate

"Inventive", "Preparation according to the invention" etc. are always based on the preparations, processes and uses according to the invention, i. also to preparations in which the uses according to the invention are realized as well as preparations with which the inventive method is realized.

The cellulose acetate-encapsulated 2,4-bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1,3,5-triazine ( INCI: bis-Ethylhexyloxyphenol methoxyphenyl triazines) can be prepared, inter alia, analogous Example 2 of WO2017 / 037716, wherein bis-Ethylhexyloxyphenol methoxyphenyl triazines instead of titanium dioxide and

Bismuthoxychlorides is used. Likewise, it can be prepared analogously to Example 2 of WO2014 / 133261 using instead of the PMMA cellulose acetate and instead of 4- (tert-butyl) -4'-methoxydibenzoylmethane the bis-ethylhexyloxyphenol methoxyphenyl triazines. The product can be obtained from Tagra Biotechnologies LTD, Netanya.

It is advantageous according to the invention if the preparation according to the invention comprises one or more further UV filters selected from the group of the compounds 4- (tert-butyl) -4'-methoxydibenzoylmethane, hexyl 2- [4- (diethylamino) -2- hydroxybenzoyl] benzoate (INCI: diethylamino hydroxybenzoyl hexyl benzoate), 2-phenylbenzimidazole-5-sulfonic acid salt, 2,4,6-tris [anilino (p-carbo-2'-ethyl-1 '-hexyloxy)] - 1, 3,5-triazine (INCI: ethylhexyl triazone), 4,4 '- [[6 - [[4 - [[(1, 1-dimethylethyl) amino] carbonyl] phenyl] amino] -1, 3,5-triazine 2,4-diyl] diimino] bis, bis (2-ethylhexyl) benzoate (INCI: diethylhexyl butamido triazone), 2,4,6-tribiphenyl-4-yl-1,3,5-triazine (INChTris-biphenyl triazine ), 2-ethylhexyl 2-hydroxybenzoate (INCI: ethylhexyl salicylate), 3,3,5-trimethylcyclohexyl 2-hydroxybenzoate (INCI: homosalate), 2,2'-methylenebis (6- (2H-benzotriazole-2-yl) yl) -4- (1,1,3,3-tetramethylbutyl) phenol), 2-ethylhexyl-2-cyano-3,3-diphenylacrylate, 2- (2H-benzotriazol-2-yl) -4- Methyl 6- [2-methyl-3- [1,3,3,3-tetr amethyl-1- [(trimethylsilyl) oxy] -1-disiloxanyl] propyl] phenol (INCI: drometrizole trisiloxane), [(3Z) -3 - [[4 - [(Z) - [7,7-dimethyl-2-] oxo-1- (sulfomethyl) -3-bicyclo [2.2.1] heptanylidenes] methyl] phenyl] methylidenes] - 7,7-dimethyl-2-oxo-1-bicyclo [2.2.1] heptanyl] methanesulfonic acid (INCI: Terephthalylidene dicamphor sulfonic acid), merocyanines, titanium dioxide, zinc oxide.

These further UV filters can advantageously be used in individual concentrations of 0.1 to 10% by weight, based on the total weight of the preparation.

It is inventively preferred when the preparation of the invention is free of 2-hydroxy-4-methoxybenzophenone, 4-methoxycinnamic acid (2-ethylhexyl) ester 4-Methoxycinntsäu- reisoamylester and / or 3- (4-methylbenzylidene) camphor. Particular preference should be given to the use of 4-methoxycinnamic acid (2-ethylhexyl) ester, 4-methoxycinnamic acid isoamyl ester 3- (4-methylbenzylidene) camphor and 2-hydroxy-4-methoxybenzophenone. In an alternative embodiment which is advantageous according to the invention, the preparation according to the invention is furthermore free of 2-ethylhexyl-2-cyano-3,3-diphenylacrylate (INCI:

Octocrylene).

It is advantageous for the purposes of the present invention, when the preparation, the 2,4-bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1, 3rd , 5-triazine (INCI: Bis-

Ethylhexyloxyphenol methoxyphenyl triazines), which is encapsulated with cellulose acetate, in an amount of 0, 1 to 15% by weight, preferably in an amount of 0.5 to 10% by weight and particularly preferably in an amount of 1 to 7% by weight , in each case based on the total weight of the preparation contains.

The weight ratio of cellulose acetate to bis-ethylhexyloxyphenol methoxyphenyl triazines in the capsules according to the invention is advantageously 20:80 to 60:40 and

Preferably according to the invention from 30:70 to 50:50 (cellulose acetate to bis-ethylhexyloxyphenol methoxyphenyl triazines).

It is inventively advantageous if the preparation of the invention in the form of a

Emulsion is present. In this case, it is preferred according to the invention if the preparation is in the form of an oil-in-water emulsion (O / W emulsion). According to the invention, the O / W emulsion is preferably in the form of a lotion.

If the preparation according to the invention is in the form of an emulsion, then the

According to the invention advantageous embodiments characterized in that the

Preparation Glyceryl stearate citrate, cetearyl alcohol, sodium cetearyl sulfate, glyceryl stearate, cetearylsulfosuccinate, sodium stearoylglutamate, polyglyceryl-3-methylglucose distearate, stearic acid, potassium cetyl phosphate, polyglyceryl-10 stearate (INCI polyglyceryl-10 stearates) and / or polyclyceryl-2 caprate.

These ingredients are advantageously used in individual concentrations of 0, 1 to 7% by weight, based on the total weight of the preparation.

It is advantageous according to the invention if the preparation according to the invention is free of polyethylene glycol, polyethylene glycol ethers and polyethylene glycol esters (so-called PEG derivatives).

Embodiments of the present invention which are advantageous according to the invention are characterized in that the preparation comprises ethylhexylglycerol, propylene glycol, butylene glycol, 2-methylpropane-1,3-diol, 1, 2-pentanediol, 1, 2-hexanediol, 1, 2-octanediol and / or 1 Contains 2-decanediol.

These compounds may be used alone or in combination in the invention

Preparation present. The use concentration according to the invention (individual concentration) is for these ingredients from 0.01 to 5% by weight, based on the total weight of the preparation.

In particular, the use of ethylhexylglycerol according to the invention is particularly advantageous. The advantageous use concentration according to the invention for ethylhexylglycerol is from 0.1 to 1% by weight, based on the total weight of the preparation.

It is advantageous according to the invention if the preparation according to the invention contains phenoxyethanol, 4-hydroxyacetophenone and / or ethanol.

Phenoxyethanol can be used according to the invention advantageously in a concentration of 0, 1 to 0.9% by weight, based on the total weight of the preparation.

According to the invention, 4-hydroxyacetophenone may advantageously be used in a concentration of up to 0.4% by weight, based on the total weight of the preparation.

According to the invention, ethanol can advantageously be used in a concentration of up to 10% by weight, based on the total weight of the preparation. Preferred according to the invention is the use of a combination of phenoxyethanol and

Ethylhexylglycerin.

Embodiments preferred according to the invention are obtained in that the

Preparation no parabens (especially propyl and Butylparaben), and no 3-iodo-2-propinylbutylcarbamat, methylisothiazolinone, chloromethylisothiazolinone and DMDM-hydantoin contains, so is free of these ingredients.

It is inventively advantageous if the preparation of the invention selected one or more of the perfume substances from the list of compounds limonene, citral, linalool, alpha-lsomethylionon, geraniol, citronellol, 2-isobutyl-4-hydroxy-4-methyltetrahydropyran, 2-tert -Pentylcyclohexylacetate, 3-methyl-5-phenyl-1-pentanol, 7-acetyl-1,1,3,4,4,6-hexamethyltetralin, adipic diester, alpha-amylcinnamaldehyde, alpha-methylionone, amyl C, butylphenylmethyl-propionalcinnamal, Amyl salicylate, amyl cinnamyl alcohol, aniseed alcohol, benzoin, benzyl alcohol, benzyl benzoate, benzyl cinnamate, benzyl salicylate, bergamot oil, bitter orange oil, butylphenylmethylpropioal, cardamom oil, cedrol, cinnamal, cinnamyl alcohol, citronellylmethyl crotonate, citrus oil, coumarin, diethyl succinate, ethyllinalool, eugenol, ethylene brassylate, Evernia furfuracea extract, Evernia Prunastri extract, farnesol, guaiac wood, geraniol, hexylcinnamal, hexyl salicylate, hydroxycitronellal, hydroxyisohexyl 3- Cyclohexene carboxaldehyde, lavender oil, lemone oil, linayl acetate, tangerine oil, menthyl PCA, methyl heptenone, nutmeg oil, rosemary oil, sweet orange oil, terpineol, tonka bean oil, triethyl citrate and / or vanillin. Embodiments of the present invention which are advantageous according to the invention are characterized in that the preparation comprises one or more oils selected from the group of the compounds butylenes glycol dicaprylate / dicaprate, phenethyl benzoate, C12-15 alkyl benzoate, dibutyl adipate; Diisopropylsebacate, Dicaprylylcarbonate, Di-C12-13 Alkyl Tartrate, Butyloctyl Salicylate, Diethylhexyl Syringylidene Malonate, Hydragenated Castor Oil Dimerate,

Triheptanoin, C12-13 alkyl lactates, C16-17 alkyl benzoates, propylheptyl caprylates,

Caprylic / capric triglycerides, diethylhexyl 2,6-naphthalates, octyldodecanol, caprylic / capric triglycerides, ethylhexyl cocoate.

These can be in single concentrations of 0, 1 to 15% by weight, based on the

Total weight of the preparation can be used.

Embodiments of the present invention which are advantageous according to the invention are also characterized in that the preparation comprises one or more compounds selected from the group of the compounds alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine, carnosine, glycyrrhetinic acid, natural and / or synthetic isoflavonoids, flavonoids, creatine, creatinine, taurine, β-alanine, panthenol, magnolol, honokiol, tocopheryl acetate, dihydroxyacetone; 8-hexadecene-1, 16-dicarboxylic acid, glycerylglycose, (2-hydroxyethyl) urea, vitamin E or its derivatives, hyaluronic acid and / or salts thereof and / or licochalcone A.

Embodiments of the present invention that are advantageous according to the invention are further characterized in that the preparation contains acrylate / C 10-30 alkyl acrylate crosspolymer and / or tricontanyl PVP.

Not least advantageous according to the invention is when the preparation according to the invention contains xanthan gum, tapioca starch and / or carboxymethyl cellulose.

It is also advantageous according to the invention if the preparation according to the invention comprises silica dimethyl silylates and / or talcum.

The preparation of the invention may advantageously contain humectants. When

Humectants (moisturizers) are substances or mixtures of substances which give cosmetic preparations the property, after application or distribution on the skin surface, the moisture release of the horny layer (also transepidermal water loss (TEWL)) and / or to positively influence the hydration of the horny layer.

The aqueous phase of the preparations according to the invention may advantageously comprise conventional cosmetic auxiliaries, such as, for example, alcohols of low C number, preferably ethanol and / or isopropanol or polyols of low C number and their ethers, electrolytes, self-tanning agents and in particular one or more thickeners or which can be advantageously selected from the group of silica, aluminum silicates, polysaccharides or their derivatives, for. As hyaluronic acid, xanthan gum, hydroxypropylmethylcellulose and / or polyacrylates (preferably a polyacrylate from the group of so-called carbopols, for example, Carbopols types 980, 981, 1382, 2984, 5984, each individually or in combination).

Measurement of the leachability

The leachability of the sunscreen from textiles can be determined, for example, by the following method:

There are sunscreen emulsions with regard to the formation of yellow spots

Cotton textiles were examined over an in vitro application / wash cycle. White prewashed cotton monitors (100% cotton) are used. For this purpose, 3 mg / cm 2 of the test formulation were distributed evenly on PMMA Schönberg plates (5.0 × 5.0 cm) and transferred directly to the test textile by means of pressure. Subsequently, the stained cotton samples are air-dried for 12 hours under laboratory conditions.

After drying, a colorimetric characterization of the resulting initial staining is carried out by measuring the degree of yellowing with the colorimeter DATACOLOR 800 (Datacolor International).

Measuring geometry: d / 8 °, SCE (gloss component excluded)

Type of light / observer: D65 / 10 ° (corresponding to average daylight)

UV filtering: adapted to D65, Ganz / Griesser method

Measuring opening: LAV (30 mm diameter)

Sample background: Base paper without optical brightener, test climate: 21 ° C (± 1 ° C), 41% (± 4%) rel. Humidity.

For evaluation the change of the b-value from the CIE-Lab color measuring system is used. The B-axis characterizes the color impression yellow / blue in the CIE-Lab system, whereby positive b-values represent an increase in the yellow component. The higher the b value, the greater the yellow impression. After the measuring process, a separate wash of

Test cloth in a washing machine) (60 ° C, 2h, Ariel Compact powder detergent, clean load). After drying for 12 h under laboratory conditions, a colorimetric is again carried out Characterization of the resulting stain by measuring the color values as already described with the colorimeter DATACOLOR 800 (Datacolor International).

The CIE-Lab System or L ^* a ^* b ^* Color Space is a three-dimensional measurement space containing all perceptible colors. The color space is based on the

Counter color theory constructed. One of the most important features of the L ^* a ^* b ^* color model is its device independence, that is, the colors are defined independently of the nature of their generation and rendering technique. The corresponding EU directive is DIN EN ISO 1 1664-4 "Colorimetry - Part 4: CIE 1976 L ^* a ^* b ^* Color space" The coordinates of the CIELAB plane are formed from the red / green value a and the yellow / Blue value b

Brightness axis L is perpendicular to this plane. According to DIN 6174, L, a and b must be written with ^* in order to distinguish themselves from others, eg the "Hunter-Lab" system.

Examples

The following examples are intended to illustrate the present invention without limiting it. All amounts, proportions and percentages are, unless stated otherwise, based on the weight and the total amount or on the total weight of the preparations.

Claims

claims

Cosmetic preparation containing 2,4-bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1, 3,5-triazine (INCI: bis-ethylhexyloxyphenol methoxyphenyl

Triazines) encapsulated with cellulose acetate.

Process for facilitating the leachability of 2,4-bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1, 3,5-triazine (INCI: Bis-Ethylhexyloxyphenol methoxyphenyl triazines), containing cosmetic preparations of textiles, characterized in that the cosmetic preparation, the 2,4-bis - {[4- (2-ethylhexyloxy) -2-hydroxy] phenyl} -6- ( 4-methoxyphenyl) -1, 3,5-triazine (INCI: bis-ethylhexyloxyphenol methoxyphenyl triazines) in encapsulated form with cellulose acetate.

Use of 2,4-bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1,3,5-triazine (INCI: bis-ethylhexyloxyphenol methoxyphenyl Triazines) that with

Cellulose acetate is encapsulated, in cosmetic preparations to facilitate the washability of this UV protection filter from contaminated with the preparations textiles.

Cosmetic preparation, process or use according to one of the preceding claims, characterized in that the preparation comprises one or more further UV filters selected from the group of the compounds 4- (tert-butyl) -4'-methoxydibenzoylmethane, hexyl 2- [4- (diethylamino) -2-hydroxybenzoyl] benzoate (INCI: diethylamino hydroxybenzoyl hexyl benzoate), 2-phenylbenzimidazole-5-sulfonic acid salt, 2,4,6-tris [anilino- (p-carbo-2'-ethyl) 1'-hexyloxy)] - 1, 3,5-triazine (INCI: ethylhexyl triazone), 4,4 '- [[6- [[4 - [[(1, 1-dimethylethyl) amino] carbonyl] phenyl] amino] -1, 3,5-triazine-2,4-diyl] diimino] bis, bis (2-ethylhexyl) benzoate (INCI: diethylhexyl butamido triazone), 2,4,6-tribiphenyl-4-yl-1,3 , 5-triazine (INCI: tris-biphenyl triazine), 2-ethylhexyl 2-hydroxybenzoate (INCI:

Ethylhexyl salicylates), 3,3,5-trimethylcyclohexyl 2-hydroxybenzoate (INCI: homosalates), 2,2'-methylenebis (6- (2H-benzotriazol-2-yl) -4- (1, 1, 3 , 3-tetramethylbutyl) -phenol), 2-ethylhexyl-2-cyano-3,3-diphenylacrylate,

2- (2H-Benzotriazol-2-yl) -4-methyl-6- [2-methyl-3- [1, 3,3,

3-tetramethyl-1 - [(trimethylsilyl) oxy] -1-disiloxanyl] propyl] phenol (INCI: drometrizole trisiloxane), [(3Z) -3 - [[4 - [(Z) - [7,7-dimethyl- 2-oxo-1 - (sulfomethyl) -3-bicyclo [2.2.1] heptanylidenes] methyl] phenyl] methylidenes] -7,7-dimethyl-2-oxo-1-bicyclo [2.2.1] heptanyl] methanesulfonic acid ( INCI: Terephthalylidene dicamphor sulphonic acid), merocyanines, titanium dioxide, zinc oxide.

Cosmetic preparation, process or use according to one of the preceding claims, characterized in that the preparation comprises the 2,

4-bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1, 3,

5-triazine (INCI: bis-ethylhexyloxyphenol methoxyphenyl triazine) encapsulated with cellulose acetate is in an amount of 1 to 7% by weight, based on the total weight of the preparation contains.

6. Cosmetic preparation, method or use according to one of the preceding claims, characterized in that the preparation is in the form of an emulsion.

Cosmetic preparation, method or use according to any one of the preceding claims, characterized in that the preparation is glyceryl stearate citrate, cetearyl alcohol, sodium cetearyl sulfate, glyceryl stearate, cetearyl sulfosuccinate

Sodium stearoylglutamate, polyglyceryl-3-methylglucose distearate, polyglyceryl-3-methylglucose distearate, stearic acid, potassium cetyl phosphate, polyglyceryl-10 stearate (INCI polyglyceryl-10 stearates) and / or polyclyceryl-2 caprate.

8. Cosmetic preparation, method or use according to one of the preceding claims, characterized in that the preparation Ethylhexylglycerin,

Propylene glycol, butylene glycol, 2-methylpropane-1, 3-diol, 1, 2-pentanediol, 1, 2-hexanediol, 1, 2-octanediol and / or 1, 2-decanediol.

9. Cosmetic preparation, method or use according to one of the preceding claims, characterized in that the preparation contains phenoxyethanol, 4-hydroxyacetophenone and / or ethanol.

10. A cosmetic preparation, method or use according to any one of the preceding claims, characterized in that the preparation of one or more of the perfume selected from the list of compounds limonene, citral, linalool, alpha-isomethylionone, geraniol, citronellol, 2-isobutyl-4 -hydroxy-4-methyltetrahydropyran, 2-tert-pentylcyclohexylacetate, 3-methyl-5-phenyl-1-pentanol, 7-acetyl-1,1,3,4,4,6-hexamethyltetralin, adipic diester, alpha-amyl-cinnamaldehyde, alpha Methyl ionone, amyl C, butylphenyl methyl propionalcinnamal, amyl salicylate, amyl cinnamyl alcohol, anisalcohol, benzoin, benzyl alcohol, benzyl benzoate, benzyl cinnamate, benzyl salicylate, bergamot oil, bitter orange oil, butylphenyl methylpropioal, cardamom oil, cedrole, cinnamal, cinnamyl alcohol, citronellylmethyl crotonate, citrus oil, coumarin,

Diethyl succinate, ethyllinalool, eugenol, ethylene brassylate, Evernia furfuracea extract, Evernia prunastri extract, farnesol, guaiac wood oil, geraniol, hexyl cinnamal,

Hexyl salicylate, hydroxycitronellal, hydroxyisohexyl 3-cyclohexene carboxaldehyde, lavender oil, lemone oil, linayl acetate, tangerine oil, menthyl PCA, methylheptenone, nutmeg oil, rosemary oil, sweet orange oil, terpineol, tonka bean oil, triethyl citrate and / or vanillin.

1 1. Cosmetic preparation, method or use according to one of

preceding claims, characterized in that the preparation is free of parabens, methylisothiazolinone, chloromethylisothiazolinone, 3-iodo-2-propynylbutylcarbamate, DMDM-hydantoin, 2-hydroxy-4-methoxybenzophenone, 4- 2-ethylhexyl methoxycinnamate, 4-methoxycinnamic acid isoamyl ester, 3- (4-methylbenzylidene) camphor.

12. A cosmetic preparation, method or use according to any one of the preceding claims, characterized in that the preparation one or more oils selected from the group of compounds butylene glycol dicaprylate / dicaprate, phenethyl benzoate, C12-15 alkyl benzoate, dibutyl adipate; Diisopropylsebacate,

Dicaprylyl carbonate, di-C12-13 alkyl tartrate, butyl octyl salicylate, diethylhexyl

Syringylidene malonates, hydrated castor oil dimerates, triheptanoin, C12-13 alkyl lactates, C16-17 alkyl benzoates, propylheptyl caprylates, caprylic / capric triglycerides, diethylhexyl 2,6-naphthalates, octyldodecanol, caprylic / capric triglycerides, ethylhexyl cocoate.

13. A cosmetic preparation, method or use according to any one of the preceding claims, characterized in that the preparation one or more

Compounds selected from the group of the compounds alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine, carnosine,

Glycyrrhetinic acid, natural and / or synthetic isoflavonoids, flavonoids, creatine, creatinine, taurine, β-alanine, panthenol, magnolol, honokiol, tocopheryl acetate,

dihydroxyacetone; 8-hexadecene-1, 16-dicarboxylic acid, glycerylglycose, (2-hydroxyethyl) urea, vitamin E or its derivatives, hyaluronic acid and / or salts thereof and / or licochalcone A.

14. A cosmetic preparation, method or use according to any one of the preceding claims, characterized in that the preparation contains acrylate / C 10-30 alkyl acrylate crosspolymer and / or tricontanyl PVP.

Cosmetic preparation, process or use according to one of the preceding claims, characterized in that the preparation contains xanthan gum,

Tapioca starch and / or carboxymethyl cellulose contains.